Medical Properties Trust Inc (MPW)

[fung_derf]

Medical Properties (MPW) Shareholder Alert: Johnson Fistel Encourages Medical Properties Shareholders with Losses to Contact the Firm Regarding Investigation
Globe Newswire11:38 AM Eastern Daylight Time Oct 06, 2022

SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.co...) is investigating whether Medical Properties Trust Inc (NYSE: MPW), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focus is on investors' losses and whether they may be recovered under federal securities laws.


What if I purchased Medical Properties Trust common stock? If you purchased Medical Properties Trust common stock and suffered significant losses on your investment, join our investigation now:


• Click or paste the following web address into your browser to submit your losses: https://www.johnsonf... Or for more information, contact Jim Baker at [e-mail] or [phone]



There is no cost or obligation to you.

What is Johnson Fistel investigating? On October 6, 2022, The Bear Cave released a report titled “More Problems at Medical Properties Trust (MPW).” The Bear Cave report claims it “uncovers a haphazard assortment of issues including distressed tenants, dubious representations, excessive spending, potential auditor independence issues, and a perplexing undisclosed entity for property management.”

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at [phone] or [e-mail].

Contact:
Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: [phone]
Email: [e-mail]